BlackRock Inc. raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 0.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 180,463 shares of the medical instruments supplier’s stock after purchasing an additional 1,681 shares during the period. BlackRock Inc. owned 4.84% of Utah Medical Products worth $16,999,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently made changes to their positions in the company. Tower Research Capital LLC TRC bought a new stake in shares of Utah Medical Products in the second quarter worth $235,000. Public Employees Retirement System of Ohio bought a new stake in shares of Utah Medical Products in the second quarter worth about $458,000. Janney Montgomery Scott LLC increased its stake in Utah Medical Products by 18.7% during the third quarter. Janney Montgomery Scott LLC now owns 4,995 shares of the medical instruments supplier’s stock worth $471,000 after acquiring an additional 786 shares during the last quarter. Advisory Services Network LLC increased its stake in Utah Medical Products by 41.7% during the third quarter. Advisory Services Network LLC now owns 5,520 shares of the medical instruments supplier’s stock worth $520,000 after acquiring an additional 1,625 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in Utah Medical Products by 140.9% during the second quarter. Bank of America Corp DE now owns 7,970 shares of the medical instruments supplier’s stock worth $877,000 after acquiring an additional 4,661 shares during the last quarter. 74.85% of the stock is owned by institutional investors.
Shares of UTMD traded up $1.98 during midday trading on Friday, hitting $93.82. 13,839 shares of the company’s stock traded hands, compared to its average volume of 10,220. Utah Medical Products, Inc. has a 1 year low of $73.98 and a 1 year high of $117.65. The firm has a market cap of $350.34 million, a PE ratio of 22.72 and a beta of 0.76.
In other news, Director Barbara A. Payne sold 1,100 shares of the stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $93.79, for a total transaction of $103,169.00. Following the completion of the sale, the director now owns 24,929 shares in the company, valued at approximately $2,338,090.91. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 8.80% of the company’s stock.
Separately, BidaskClub upgraded Utah Medical Products from a “hold” rating to a “buy” rating in a report on Tuesday, February 5th.
ILLEGAL ACTIVITY WARNING: “BlackRock Inc. Purchases 1,681 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)” was originally posted by Fairfield Current and is owned by of Fairfield Current. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark copyright laws. The correct version of this report can be read at https://www.fairfieldcurrent.com/news/2019/02/11/blackrock-inc-purchases-1681-shares-of-utah-medical-products-inc-utmd.html.
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
Further Reading: How interest rates affect municipal bond prices
Receive News Ratings for Utah Medical Products Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Utah Medical Products and related companies with MarketBeat.com’s FREE daily email newsletter.